Oncoinvent ASA
Developing alpha-emitting radiotherapies for treating cancers in the peritoneal cavity.
OCIN | Euronext Growth
Overview
Corporate Details
- ISIN(s):
- NO0010779341 (+1 more)
- LEI:
- 54930076H5GUZRMSNR39
- Country:
- Norway
- Address:
- Gullhaugveien 7, 0484 Oslo
- Website:
- https://www.oncoinvent.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Oncoinvent ASA is a clinical-stage biotechnology company dedicated to developing innovative radiopharmaceutical products for cancer treatment. The company's core focus is on direct alpha therapy. Its lead product candidate, Radspherin®, is an alpha-emitting therapeutic designed for treating cancers within the peritoneal cavity, such as metastatic colorectal and ovarian cancers. The technology utilizes biodegradable, inorganic microparticles as carriers for alpha-emitters, enabling the delivery of high-power, short-range radiation directly to tumors. This approach ensures regional retention of the effective radiation dose while minimizing systemic exposure. Oncoinvent is actively advancing its product pipeline through clinical trials, including a Phase 2 program for Radspherin® in ovarian cancer patients.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-17 08:56 |
Share Issue/Capital Change
Oncoinvent ASA: Updated information regarding the contemplated Rights Issue and…
|
English | 89.4 KB | ||
| 2025-09-17 08:56 |
Share Issue/Capital Change
Oncoinvent ASA: Updated information regarding the contemplated Rights Issue and…
|
English | 3.2 KB | ||
| 2025-09-17 08:55 |
Share Issue/Capital Change
Oncoinvent ASA: Updated Key Information related to the contemplated Rights Issu…
|
English | 93.4 KB | ||
| 2025-09-17 08:55 |
Share Issue/Capital Change
Oncoinvent ASA: Updated Key Information related to the contemplated Rights Issue
|
English | 9.6 KB | ||
| 2025-08-27 07:00 |
Earnings Release
Oncoinvent ASA half-yearly report: Strong focus on financial discipline and adv…
|
English | 135.5 KB | ||
| 2025-08-27 07:00 |
Investor Presentation
Oncoinvent ASA half-yearly report: Strong focus on financial discipline and adv…
|
English | 1.2 MB | ||
| 2025-08-27 07:00 |
Interim Report
Oncoinvent ASA half-yearly report: Strong focus on financial discipline and adv…
|
English | 647.1 KB | ||
| 2025-08-27 07:00 |
Earnings Release
Oncoinvent ASA half-yearly report: Strong focus on financial discipline and adv…
|
English | 4.5 KB | ||
| 2025-08-22 12:22 |
Report Publication Announcement
Oncoinvent ASA invites to a webcast presentation of 1H 2025 on Wednesday 27 Aug…
|
English | 4.2 KB | ||
| 2025-08-04 13:53 |
Post-Annual General Meeting Information
Oncoinvent shareholders approve the merger plan with BerGenBio - Attachment: On…
|
Norwegian | 111.8 KB | ||
| 2025-08-04 13:53 |
Post-Annual General Meeting Information
Oncoinvent shareholders approve the merger plan with BerGenBio
|
English | 4.4 KB | ||
| 2025-07-03 15:45 |
Pre-Annual General Meeting Information
Oncoinvent ASA: Notice of Extraordinary General Meeting - Attachment: Oncoinven…
|
Norwegian | 190.2 KB | ||
| 2025-07-03 15:45 |
Pre-Annual General Meeting Information
Oncoinvent ASA: Notice of Extraordinary General Meeting
|
English | 3.6 KB | ||
| 2025-06-30 22:11 |
Share Issue/Capital Change
Announcement of fully underwritten rights issue - Attachment: Attachment_overvi…
|
English | 101.2 KB | ||
| 2025-06-30 22:11 |
Share Issue/Capital Change
Announcement of fully underwritten rights issue - Attachment: Joint_Press_Relea…
|
English | 143.1 KB |
Automate Your Workflow. Get a real-time feed of all Oncoinvent ASA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Oncoinvent ASA via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
